CD83 expressed by macrophages is an important immune checkpoint molecule for the resolution of inflammation

Front Immunol. 2023 Feb 15:14:1085742. doi: 10.3389/fimmu.2023.1085742. eCollection 2023.

Abstract

Excessive macrophage (Mφ) activation results in chronic inflammatory responses or autoimmune diseases. Therefore, identification of novel immune checkpoints on Mφ, which contribute to resolution of inflammation, is crucial for the development of new therapeutic agents. Herein, we identify CD83 as a marker for IL-4 stimulated pro-resolving alternatively activated Mφ (AAM). Using a conditional KO mouse (cKO), we show that CD83 is important for the phenotype and function of pro-resolving Mφ. CD83-deletion in IL-4 stimulated Mφ results in decreased levels of inhibitory receptors, such as CD200R and MSR-1, which correlates with a reduced phagocytic capacity. In addition, CD83-deficient Mφ upon IL-4 stimulation, show an altered STAT-6 phosphorylation pattern, which is characterized by reduced pSTAT-6 levels and expression of the target gene Gata3. Concomitantly, functional studies in IL-4 stimulated CD83 KO Mφ reveal an increased production of pro-inflammatory mediators, such as TNF-α, IL-6, CXCL1 and G-CSF. Furthermore, we show that CD83-deficient Mφ have enhanced capacities to stimulate the proliferation of allo-reactive T cells, which was accompanied by reduced frequencies of Tregs. In addition, we show that CD83 expressed by Mφ is important to limit the inflammatory phase using a full-thickness excision wound healing model, since inflammatory transcripts (e.g. Cxcl1, Il6) were increased, whilst resolving transcripts (e.g. Ym1, Cd200r, Msr-1) were decreased in wounds at day 3 after wound infliction, which reflects the CD83 resolving function on Mφ also in vivo. Consequently, this enhanced inflammatory milieu led to an altered tissue reconstitution after wound infliction. Thus, our data provide evidence that CD83 acts as a gatekeeper for the phenotype and function of pro-resolving Mφ.

Keywords: CD83; STAT-6; checkpoint molecule; macrophages; resolution of inflammation; wound healing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Immune Checkpoint Proteins*
  • Inflammation
  • Interleukin-4*
  • Macrophages
  • Mice
  • Phagocytes

Substances

  • Immune Checkpoint Proteins
  • Interleukin-4

Grants and funding

This work was supported by the Deutsche Forschungsgemeinschaft (DFG) within grants CRC1181 project B03 and STE432/15-1 (both to ASte), ZI 1225/1-1 (to EZ), MA 2621/4-1 and MA 2621/5-1 (to JM and MW). By the Interdisciplinary Center of Clinical Research (IZKF) at the University Hospital Erlangen to ASte (grant A89), to AW (grant P062), to DR (grant ELAN P077), and to KP-M (grant P105). By the Else Kroner-Fresenius-Stiftung to AW (grant 2020_EKEA.81). KP-M was funded by the Bavarian Equal Opportunities Sponsorship – Realization Equal Opportunities for Women in Research and Teaching. ASte was further supported by the m4 Award (grant M4-2110-0003), sponsored by the Bavarian State Ministry of Economic Affairs and Media, Energy and Technology.